Chemoinformaics analysis of 5-HYDROXY-6,7-DIMETHOXY-2-METHYLCHROMEN-4-ONE
| Molecular Weight | 236.223 | nRot | 2 |
| Heavy Atom Molecular Weight | 224.127 | nRig | 23 |
| Exact Molecular Weight | 236.068 | nRing | 2 |
| Solubility: LogS | -4.16 | nHRing | 1 |
| Solubility: LogP | 3.633 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 11 |
| nHA | 5 | APOL | 32.0515 |
| nHD | 1 | BPOL | 18.1145 |
| QED | 0.443 |
| Synth | 3.866 |
| Natural Product Likeliness | 2.06 |
| NR-PPAR-gamma | 0.911 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.993 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.808 |
| MDCK | 0.0000284 |
| BBB | 0.225 |
| PPB | 0.976999 |
| VDSS | 0.953 |
| FU | 0.0239974 |
| CYP1A2-inh | 0.105 |
| CYP1A2-sub | 0.114 |
| CYP2c19-inh | 0.221 |
| CYP2c19-sub | 0.788 |
| CYP2c9-inh | 0.493 |
| CYP2c9-sub | 0.843 |
| CYP2d6-inh | 0.529 |
| CYP2d6-sub | 0.474 |
| CYP3a4-inh | 0.447 |
| CYP3a4-sub | 0.243 |
| CL | 1.907 |
| T12 | 0.234 |
| hERG | 0.031 |
| Ames | 0.729 |
| ROA | 0.624 |
| SkinSen | 0.234 |
| Carcinogencity | 0.783 |
| EI | 0.077 |
| Respiratory | 0.933 |
| NR-Aromatase | 0.908 |
| Antiviral | No |
| Prediction | 0.633894 |